Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

CASELLA JAMES — NEUROGEN CORP insider: 1 transactions · InsiderLens

Home / Insiders / CASELLA JAMES

CASELLA JAMES

Sr. VP Clinical Development at NEUROGEN CORP · on record since Dec 18, 2003

Insider trading activity of CASELLA JAMES

Transactions on record: 1; since Dec 18, 2003

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 18, 2003

Figures computed from official regulatory filings — methodology.

Companies where CASELLA JAMES has traded

NEUROGEN CORP1 tx · Dec 18, 2003

Track record of CASELLA JAMES

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of CASELLA JAMES

Co-insiders of CASELLA JAMES

Baker Biotech Capital (GP), LLCNEUROGEN CORP
Baker Biotech Capital II (GP), LLCNEUROGEN CORP
Baker Biotech Capital III (GP), LLCNEUROGEN CORP
Baker Biotech Capital II (Z) (GP), LLCNEUROGEN CORP
Baker Bros. Capital (GP), LLCNEUROGEN CORP
BAKER FELIXNEUROGEN CORP
BAKER JULIANNEUROGEN CORP

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Baker / Tisch Capital (GP), LLCNEUROGEN CORP

BIOTECHNOLOGY VALUE FUND II LPNEUROGEN CORP

BIOTECHNOLOGY VALUE FUND L PNEUROGEN CORP

BLOOM BARRYNEUROGEN CORP

BROSHY ERANNEUROGEN CORP

BUTLER ROBERT NNEUROGEN CORP

BVF INC/ILNEUROGEN CORP

BVF INVESTMENTS LLCNEUROGEN CORP

BVF PARTNERS L P/ILNEUROGEN CORP

CARLUCCI FRANK CNEUROGEN CORP

Chenard Bertrand LNEUROGEN CORP

DAVIS STEPHENNEUROGEN CORP

Dill JeffreyNEUROGEN CORP

HEN STEWARTNEUROGEN CORP

HUTCHISON ALANNEUROGEN CORP

KAYE CHARLES RNEUROGEN CORP

KOSTER WILLIAM HNEUROGEN CORP

KRAUSE JAMESNEUROGEN CORP

LAMATTINA JOHN LNEUROGEN CORP

LANDY JOSEPHNEUROGEN CORP

LEE LAI FOONNEUROGEN CORP

LEFF JONATHAN SNEUROGEN CORP

NOVITCH MARK M DNEUROGEN CORP

Ochoa RicardoNEUROGEN CORP

Pitler Thomas A.NEUROGEN CORP

Ritrovato CharlesNEUROGEN CORP

SAXTON CRAIGNEUROGEN CORP

SHAW KENNETHNEUROGEN CORP

SIMON JOHNNEUROGEN CORP

Stack W. AndrewNEUROGEN CORP

Stankovic Srdjan R.NEUROGEN CORP

TISCH ANDREW HNEUROGEN CORP

TISCH DANIEL RNEUROGEN CORP

TISCH JAMES SNEUROGEN CORP

TISCH THOMAS JNEUROGEN CORP

Uden StephenNEUROGEN CORP

WARBURG PINCUS & CONEUROGEN CORP

WARBURG PINCUS LLCNEUROGEN CORP

Warburg Pincus Partners LLCNEUROGEN CORP

WARBURG PINCUS PRIVATE EQUITY VIII L PNEUROGEN CORP

WOOLSEY SUZANNENEUROGEN CORP

Company	Filed	Type	Qty	Price	Value · USD	Src
NEUROGEN CORP	Dec 18, 2003	AwardD	27,000	0.00 USD	—	SEC